NPI: 1184647620 · TUALATIN, OR 97062 · Clinic/Center · NPI assigned 07/25/2006
Authorized official JENSEN, SARAH controls 20+ related entities in our dataset. Read more
| Authorized Official | JENSEN, SARAH (VP FINANCE) |
| NPI Enumeration Date | 07/25/2006 |
Other providers sharing the same authorized official: JENSEN, SARAH
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 15,884 | $1.20M |
| 2019 | 16,457 | $1.51M |
| 2020 | 13,371 | $1.37M |
| 2021 | 19,725 | $1.91M |
| 2022 | 26,796 | $2.32M |
| 2023 | 25,315 | $2.53M |
| 2024 | 22,996 | $2.44M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 14,502 | 13,110 | $4.59M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 17,717 | 16,358 | $4.30M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 16,194 | 14,762 | $2.76M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 8,650 | 7,889 | $1.04M |
| 96361 | Intravenous infusion, hydration; each additional hour | 1,514 | 1,260 | $157K |
| 96375 | Therapeutic injection; each additional sequential IV push | 3,697 | 3,352 | $149K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 932 | 881 | $84K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 626 | 593 | $53K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 157 | 151 | $36K |
| 71045 | Radiologic examination, chest; single view | 634 | 554 | $27K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 250 | 198 | $21K |
| 71046 | Radiologic examination, chest; 2 views | 397 | 363 | $14K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 442 | 330 | $12K |
| 70450 | Computed tomography, head or brain; without contrast material | 69 | 65 | $7K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,345 | 1,061 | $6K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 100 | 98 | $5K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 7,656 | 6,861 | $4K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 28 | 24 | $3K |
| 80053 | Comprehensive metabolic panel | 15,627 | 14,285 | $3K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 26,623 | 24,197 | $2K |
| 87631 | 378 | 346 | $2K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 100 | 98 | $1K |
| 71271 | 13 | 12 | $880.07 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 932 | 719 | $704.67 |
| 80048 | Basic metabolic panel (calcium, ionized) | 3,482 | 3,196 | $292.97 |
| 36415 | Collection of venous blood by venipuncture | 4,074 | 3,689 | $143.25 |
| G0297 | Low dose ct scan (ldct) for lung cancer screening | 12 | 12 | $142.88 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 112 | 86 | $135.00 |
| 84703 | 1,799 | 1,674 | $128.73 | |
| 83690 | 2,255 | 2,099 | $74.57 | |
| 84484 | 2,411 | 2,132 | $65.32 | |
| 81003 | 2,942 | 2,773 | $45.25 | |
| 83735 | 404 | 370 | $6.03 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 2,391 | 2,167 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 13 | 13 | $0.00 |
| 36592 | 13 | 13 | $0.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 1,025 | 851 | $0.00 |
| 81001 | 162 | 155 | $0.00 | |
| 82077 | 305 | 279 | $0.00 | |
| 85027 | 280 | 255 | $0.00 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 52 | 49 | $0.00 |
| 96376 | 12 | 12 | $0.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 47 | 44 | $0.00 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 43 | 39 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 78 | 62 | $0.00 |
| A9270 | Non-covered item or service | 18 | 16 | $0.00 |
| 87430 | 31 | 28 | $0.00 |